DRUG SUPPLIED DOSE COMMENTS
ROPIVACAINE (Paeds)
(Naropin)

Mechanism of action:

Long-acting amide local anaesthetic agent.



Ref: 32, 566-71


Last update: 2022-09-10		 Injection: 0.2% (2 mg/mL), 0.3% (3 mg/mL), 0.5% (5 mg/mL), 1% (10 mg/mL)

 Peripheral nerve/Caudal block (Preservative Free):
Peripheral Nerve Single dose:
0.25 - 3 mg/kg/dose. Max 200 mg/dose
Caudal Block Single dose:
0.5 - 2 mg/kg/dose. Max 100 mg/dose
Infusion:
0.1 - 0.4 mg/kg/hr
Max 0.2 mg/kg/hr if ≤ 6 months age

Continuous Epidural Infusion (Preservative Free):
<= 6 months age:  0.1 - 0.2 mg/kg/hr
> 6 months age: 0.1 - 0.4 mg/kg/hr		 Solutions containing preservatives must not be used for epidural infusions or caudal/peripheral blocks.

Duration of action 3-10 hours.

Risk of resuscitation-resistant cardiotoxicity with toxic doses or inadvertent intravascular injection.

Treatment of cardiotoxicity includes standard resuscitation measures and lipid emulsion bolus and infusion doses (see intralipid monograph).

Refer to "Postoperative Disposition Guidelines for Infants" for epidural use in infants on PHSA SHOP.



Standard Prescription:

ropivicaine __ mg/kg/dose {site}
ropivicaine __ mg/kg/hr {site}